Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Southern Acids (M) BhdXKLS:5134 +1.31%69 FCF Margin % is 21.56% as of Mar. 2026, which is 589% above its 10-year median of 3.13. GuruFocus rates XKLS:5134 with a GF Score™ of 69/100 and a GF Value™ of RM2.88 (Fairly Valued). The stock has 4 warning signs investors should review. Among 551 Conglomerates companies, Southern Acids (M) Bhd ranks better than 73.68% on this metric.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Conglomerates subindustry, Southern Acids (M) Bhd's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Southern Acids (M) Bhd FCF Margin % vs Conglomerates Industry
For the Conglomerates industry and Industrials sector, Southern Acids (M) Bhd's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Southern Acids (M) Bhd's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Southern Acids (M) Bhd (XKLS:5134) has a FCF Margin % of 21.56% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Southern Acids (M) Bhd and its competitors. This is 589% above median its historical median of 3.13. According to the industry distribution chart, Southern Acids (M) Bhd ranks #145 out of 551 companies in the Conglomerates industry, placing it in the top 26.3%.
Is Southern Acids (M) Bhd's FCF Margin % too high?
Southern Acids (M) Bhd's current FCF Margin % of 21.56% is 589% above median its 10-year median of 3.13. The Conglomerates industry median FCF Margin % is 2.59. Southern Acids (M) Bhd's value of 21.56% is 732.4% above this industry median. Based on the distribution chart, Southern Acids (M) Bhd ranks #145 out of 551 companies in the Conglomerates industry, which is above the industry midpoint. Overall, Southern Acids (M) Bhd has a GF Score™ of 69/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Southern Acids (M) Bhd's FCF Margin % compare to HON and MMM?
According to the Conglomerates industry distribution chart, Southern Acids (M) Bhd ranks #145 out of 551 companies for FCF Margin %. This puts Southern Acids (M) Bhd in the upper half of its industry. The industry median FCF Margin % is 2.59. Southern Acids (M) Bhd's value of 21.56% is 732.4% above this benchmark. While the company's 10-year median is 3.13 vs. the industry median of 2.59, Southern Acids (M) Bhd has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Conglomerates company?
The median FCF Margin % among Conglomerates companies is 2.59, based on 551 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Southern Acids (M) Bhd's current FCF Margin % of 21.56% is 732.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Southern Acids (M) Bhd and its competitors. For the Conglomerates industry, the median FCF Margin % is 2.59 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Southern Acids (M) Bhd's current FCF Margin % is 21.56%, which is 589% above median its own 10-year median of 3.13. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Southern Acids (M) Bhd stock overvalued right now?
Based on GuruFocus' analysis, Southern Acids (M) Bhd (XKLS:5134) is currently considered Fairly Valued. The stock's GF Value™ is RM2.88, compared to a current price of RM3.10 — trading 7.6% above its estimated fair value. The current FCF Margin % is 21.56%, which is 589% above median its 10-year median of 3.13 and 732.4% above the Conglomerates industry median of 2.59. Southern Acids (M) Bhd's overall GF Score™ is 69/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Southern Acids (M) Bhd (XKLS:5134), the current FCF Margin % is 21.56% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Southern Acids (M) Bhd (XKLS:5134) Overvalued in 2026?
Based on GuruFocus' analysis, Southern Acids (M) Bhd stock appears to be overvalued.
The current stock price of RM3.10 is trading 7.6% above its estimated GF Value™ of RM2.88.
GuruFocus considers Southern Acids (M) Bhd to be Fairly Valued.
Key valuation signals for XKLS:5134:
FCF Margin %: 21.56% (589% above median its 10-year median of 3.13)
GF Value™: RM2.88 vs. price of RM3.10 (7.6% above fair value)
Industry Position: 732.4% above the Conglomerates median (#145 of 551)
No single metric tells the full story. See the XKLS:5134 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Southern Acids (M) Bhd is an investment holding and the provision of a management service company. The company's operating segment includes Oleochemical; Healthcare; Milling and Cultivation and Investments and services. It generates maximum revenue from the Milling and Cultivation segment. The Oleochemical Segment is involved in the manufacturing and marketing of fatty acids and glycerine. Its Milling and Cultivation Segment is principally engaged in the processing of Fresh Fruit Bunches. Geographically, it has a presence in Malaysia, Indonesia, Europe, America, and Other Countries.
69GF Score
Get the complete analysis for XKLS:5134
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:5134 has been successfully added to your 
